Blog

AI, HTA, and the future of access: Inside the 12th annual Kraków HTA symposium

Explore key insights from the 12th Annual Kraków HTA Symposium covering HTA, reimbursement policy, AI…

Simona ColucciJuly 8, 2026

Blog

How interactive value communication tools strengthen the value proposition in healthcare

Learn how interactive value communication tools help demonstrate healthcare value, support payer discussions, and strengthen…

CertaraJune 9, 2026

Blog

The end of the national launch: Why regional pharma market access now determines commercial success

Regional pharma market access is reshaping uptake. Build a regional market access strategy to navigate…

CertaraJune 5, 2026

Blog

Strategies for navigating loss of exclusivity (LOE) in pharma

Learn key strategies to navigate loss of exclusivity with confidence & defend market share throughout…

Christian PichardoJune 2, 2026

Blog

Best practices for pharma commercialization in market access

Learn best practices for your pharma commercialization strategy. See how to localize content in pharma…

Daria LavrentevMay 12, 2026

Blog

Interactive global value dossiers: Turning evidence into market access impact

Learn how an interactive global value dossier improves stakeholder engagement and streamlines value dossier preparation…

Christian PichardoMarch 25, 2026

Blog

The future of payer engagement in pharma: Rethinking how value is communicated

A detailed analysis of strategies for payer engagement in pharma and how digital payer engagement…

Christian PichardoMarch 19, 2026

Blog

How dynamic cost calculators can be used in health economics to empower market access teams

Learn how dynamic HEOR cost calculators support budget impact, cost-effectiveness, and payer engagement to strengthen…

CertaraFebruary 19, 2026

Blog

From cost center to value driver: Making the case for total value of ownership (TVO) in life sciences

Shift from Total Cost of Ownership to Total Value of Ownership in life sciences, showcasing…

CertaraOctober 16, 2025

Blog

U.S. international reference pricing: Global implications and pharma strategy

Unintended global fallout of international reference pricing: How the U.S. Most Favored Nation policy could…

CertaraOctober 6, 2025

Market Access and Pricing

AI, HTA, and the future of access: Inside the 12th annual Kraków HTA symposium

How interactive value communication tools strengthen the value proposition in healthcare

The end of the national launch: Why regional pharma market access now determines commercial success

Strategies for navigating loss of exclusivity (LOE) in pharma

Best practices for pharma commercialization in market access

Interactive global value dossiers: Turning evidence into market access impact

The future of payer engagement in pharma: Rethinking how value is communicated

How dynamic cost calculators can be used in health economics to empower market access teams

From cost center to value driver: Making the case for total value of ownership (TVO) in life sciences

U.S. international reference pricing: Global implications and pharma strategy

Newsletter sign up

Quick links

Solutions

Contact